Format

Send to

Choose Destination
Haematologica. 2019 Feb 21. pii: haematol.2018.211615. doi: 10.3324/haematol.2018.211615. [Epub ahead of print]

Sorafenib improves survival of FLT3-mutated acute myeloid leukemia in relapse after allogeneic stem cell transplantation: a report of EBMT acute leukemia Working Party.

Author information

1
American University of Beirut; bazarbac@aub.edu.lb.
2
Hôpital Saint Antoine.
3
University Hospital, Hematology, Basel.
4
Hôpital Saint Louis, Department of Hematology, BMT, Paris.
5
CHU Bordeaux Hôpital Haut-leveque, Pessac.
6
Departement d'Hematologie et Oncologie pédiatrique.
7
CHU Hotel Dieu.
8
CHRU, Service des Maladies du Sang, Angers.
9
Erasmus MC-Daniel den Hoed Cancer Center.
10
University Tor Vergata of Rome.
11
CHU Caen.
12
Hopital Saint Antoine.
13
AUBMC.
14
Hospital Clinic.
15
Chaim Sheba Medical Center.
16
Hôpital Saint-Antoine.

KEYWORDS:

Acute Myeloid Leukemia; FLT3-mutated; Relapse; Sorafenib; Stem Cell Transplantation

PMID:
30792203
DOI:
10.3324/haematol.2018.211615
Free full text

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center